SCHEMBL5049360

SCHEMBL5049360

CCNc1cc(Nc2cc(OC3CCNCC3)ncn2)c(F)cc1C#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.37
CHEK1 O14757 4/20 0.36
CHEK2 O96017 2/20 0.36
CDK2 P24941 2/20 0.36
CDK6 Q00534 2/20 0.36
CSNK2A2 P19784 1/20 0.36
CSNK2A1 P68400 1/20 0.36
CCNT1 O60563 1/20 0.36
CCNA2 P20248 1/20 0.36
CCND3 P30281 1/20 0.36
CDK7 P50613 1/20 0.36
CDK9 P50750 1/20 0.36
CCNH P51946 1/20 0.36
MNAT1 P51948 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
TBK1 Q9UHD2 6/20 0.35
FLT3 P36888 3/20 0.35
AXL P30530 2/20 0.33
TYRO3 Q06418 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4269127 0.87 CSNK2A2 (0.43) GPR119CHEK1CHEK2CDK2CDK6
SCHEMBL391902 0.81 GPR119 (0.51) GPR119TBK1IKBKE
SCHEMBL4721855 0.80 GPR119 (0.41) GPR119CDK2CDK6CCNT1CCNA2
SCHEMBL5049760 0.80 GPR119 (0.43) GPR119CDK2CDK6CSNK2A2CSNK2A1
SCHEMBL5046883 0.79 GPR119 (0.39) GPR119CHEK1CHEK2CDK2CDK6
SCHEMBL27747809 0.77 GPR119 (0.39) GPR119CDK2CDK6CCNT1CCNA2
SCHEMBL5264798 0.76 GPR119 (0.41) GPR119CDK2CDK6CCNT1CCNA2
SCHEMBL5048550 0.74 GPR119 (0.49) GPR119CDK2CDK6CCNT1CCNA2
SCHEMBL5046882 0.73 GPR119 (0.46) GPR119CDK2CDK6CCNT1CCNA2
SCHEMBL5190352 0.71 GPR119 (0.49) GPR119CDK2CDK6CCNT1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004157-A2 USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AS WELL AS COMBINATION THERAPY RELATING THERETO Arena Pharmaceuticals, Inc. (US) 2008-12-24 EP disclosed
WO-2007120702-A2 USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AND COMBINATION THERAPY RELATING THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-10-25 WO disclosed